You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML in blast crisis

Showing 1 - 25 of 1,471
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

Chronic Myeloid Leukemia in Myeloid Blast Crisis Trial in Worldwide

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • Brno, Czechia
    • +8 more
    Jan 27, 2021

    B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Chicago, Illinois
    • +5 more
    Dec 27, 2021

    Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

    Completed
    • Myelodysplastic Syndrome RAEB-I or RAEB-II
    • +2 more
    • GM-CSF secreting leukemia vaccine
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 28, 2022

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

    Completed
    Has Results
    • Philadelphia Chromosome Positive CML
    • imatinib mesylate
    • Chicago, Illinois
    • +9 more
    Jun 3, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2022

    Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

    Terminated
    • Accelerated Phase Chronic Myelogenous Leukemia (CML)
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2020

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +2 more
    • Clofarabine 40mg/m^2
    • +5 more
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 3, 2020

    Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

    Withdrawn
    • Accelerated Phase MPN
    • Blast Phase MPN
    • (no location specified)
    Nov 4, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Orca-Q
    • Gainesville, Florida
      University of Florida
    Aug 26, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • XmAb14045
    • Jacksonville, Florida
    • +8 more
    Mar 4, 2022

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

    Completed
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
      • Limerick, Dooradoyle, Ireland
      • +32 more
      Aug 13, 2021

      Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

      Recruiting
      • Accelerated/Blast-phase Myeloproliferative Neoplasm
      • +2 more
      • Scottsdale, Arizona
      • +10 more
      May 9, 2022

      Leukemia, Myeloid, Chronic Trial in Germany, United States (LBH589)

      Terminated
      Has Results
      • Leukemia, Myeloid, Chronic
      • Duarte, California
      • +25 more
      Jul 14, 2021

      Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

      Completed
      Has Results
      • Chronic Myelogenous Leukemia
      • +3 more
      • Duarte, California
      • +100 more
      Jun 8, 2021

      Vascular Occlusive Events Associated With ICLUSIG®

      Terminated
      • Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
        • Hackensack, New Jersey
        • +1 more
        Oct 30, 2020

        According to Molecular Identification at Diagnosis

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Next Generation Sequencing (DNA and RNA)
        • (no location specified)
        Oct 28, 2022

        Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

        Not yet recruiting
        • Leukemia
        • +12 more
        • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
        • (no location specified)
        Mar 20, 2023